Palo Alto, California, June 9, 2010 – OroScience plc (Palo Alto, CA), in conjunction with Ace Surgical Supply, Inc. (Brockton, MA), will be exhibiting and introducing Periogenix at the 10th International Symposium for Periodontics & Restorative Dentistry in Boston, Massachusetts from June 10th to 12th, 2010. Sponsored by the International Quintessence Publishing Group, publisher of The International Journal of Periodontics & Restorative Dentistry, and the American Academy of Periodontology, this symposium addresses current trends in periodontal surgery and implant and esthetic dentistry. The symposium offers the attendees from 57 countries and all 50 U.S. states daily cutting-edge sessions presented by 84 world-renowned clinicians and clinical researchers.
Periogenix™ is a new oral wound dressing technology intended to protect injured periodontal tissue (gums) by forming a temporary physical barrier to avoid further irritation. Periogenix™ helps clinicians manage oral wounds by providing a barrier to assist in the process of acute and chronic wound healing. Clinical and animal studies demonstrate that Periogenix™ protects and safely promotes the healing of post-operative surgical wounds.
About OroScience
OroScience is a global professional oral care company dedicated to providing advanced therapies for the professional management of oral conditions such as oral wounds and mucositis. Our mission, helping nature heal, is woven into the fabric of OroScience’s organization and vision. In collaboration with leading clinicians, we develop, manufacture, and sell proprietary therapeutic dental and oral care products for oral wound healing, tissue regeneration, and oral disease management.
** END OF PRESS RELEASE **
OroScience plc is an independent, stock exchange listed manufacturer of professional oral care products. This news release may contain certain forward-looking statements, expectations, intentions, strategies and beliefs regarding the future. All statements contained herein are based upon information available to the management of OroScience plc as of the date hereof, and actual results may vary based upon future events, both within and without the control of the management, including risks and uncertainties that could cause actual results to differ materially.
Management does not take any responsibility to update the contents of this News Release in case new aspects arise or new conditions change the facts available.
OroScience plc
2275 E. Bayshore Rd., Suite 105
Palo Alto, CA 94301 USA
www.oroscience.com
ISIN IE00B40WCY19, WKN A0X9H7,
Exchange: Vienna stock exchange, Frankfurt Stock Exchange
Media Contact: OroScience
Phil Houle
Chief Operations Officer
phoule@oroscience.com
